1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. CATALYST PHARMACEUTICALS INC
Catalyst Pharmaceuticals Inc XNAS: CPRX

Catalyst Pharmaceuticals Inc Live Stock Price Today, Share Analysis and Chart

Value Stock, Under Radar
about

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAP...

Read More
19.52 0.39 (2.04%)
New 52W Low in past week
1.2M
XNAS Volume

XNAS 26 Sep, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Durability score
High Financial Strength
72.2 / 100
Valuation Score
Affordable Valuation
57.7 / 100
Momentum Score
Technically Bearish
31.6 / 100
Value Stock, Under Radar These stocks are strong in quality and valuation, but score weak in technical aspects. Hence, it is better to wait for the stock to change their momentum. View Similar Embed DVM
Analyst Price Target
34
1Yr Price target upside is 76%
7 analysts

12

S

8

W

6

O

0

T

SWOT Analysis

Catalyst Pharmaceuticals Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..